NAMS

18.4105.64%
RW

Robert W. Gunning

Principal Accounting Officer, VP & Controller

Mr. Robert W. Gunning, CPA, CGMA., serves as Vice President and Controller at NewAmsterdam Pharma Company N.V. from August 10, 2026 and is its Principal Accounting Officer from August 31, 2026. He is an experienced accounting and finance professional with experience working with public and private companies. Prior to joining NewAmsterdam Pharma Company N.V., Mr. Gunning served as Interim Controller and a consultant on other financial and accounting matters to Altimmune, Inc., a biopharmaceutical company, from April 2026 until July 2026. From April 2022 until April 2026, Mr. Gunning served as Vice President Finance and Corporate Controller at Y-mAbs Therapeutics, Inc., a biopharmaceutical company, that was acquired by SERB Pharmaceuticals, a global specialty pharmaceutical company. From August 2021 until April 2022, he served as Vice President and Controller at Excision BioTherapeutics Inc., a biotechnology company. Prior to that, Mr. Gunning was the Chief Financial Officer (US) and Head of Finance Transformation at Advanced Accelerator Applications USA, Inc., a pharmaceutical company owned by Novartis and a Novartis AG subsidiary, where he executed financial strategies to support project launches and sales growth of LUTATHERA® and NETSPOT®. Previously, Mr. Gunning was the Director of Financial Reporting and Director of SEC Reporting for Amec Foster Wheeler plc, where he was responsible for the company's financial filings with the U.S. Securities and Exchange Commission. Mr. Gunning also led the post-acquisition purchase price allocation for Amec plc's acquisition of Foster Wheeler AG and was responsible for the post-acquisition financial reporting integration of the legacy Foster Wheeler entities, including conversion from U.S. GAAP to IFRS. Prior to joining Amec Foster Wheeler, Mr. Gunning was Vice President, Finance and Director of Financial Report, Planning and Analysis at Home Décor Products, Inc., where he managed a team of seventeen, overseeing general accounting, inventory and accounts receivable and payable. He was previously a Finance Manager at Ethicon, Inc., a Johnson & Johnson company, where he was responsible for monthly and quarterly international reporting requirements and financial statements. Mr. Gunning is a Certified Public Accountant in the State of New York and holds a BBA in Public Accounting from Pace University.

Positions